Hepatic lipase C-514T polymorphism and its association with high-density lipoprotein cholesterol level in Tehran

European Journal of Preventive Cardiology

Volumn 13, Issue 1, 2006, Pages 101-103

  Daneshpour, Maryam S ^a   Hedayati, Mehdi ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

data quality; epidemiology; reporting; response rate

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CORONARY RISK; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; IRAN; MALE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; ALLELES; BODY MASS INDEX; CHOLESTEROL, HDL; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMANS; IRAN; LIPASE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PHENOTYPE; POLYMORPHISM, GENETIC; SMOKING;

EID: 33646110251     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1097/01.hjr.0000183908.74989.0c     Document Type: Article

References (14)

1. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischemic heart disease. Lancet 1975; 1: 16–19.
2. Després JP. Dyslipidaemia and obesity. Baillieres Clin Endocrinol Metab 1994; 8: 629–660.
3. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269: 3015–3023.
4. Funke H. Genetic determinants of high-density lipoprotein levels. Curr Opin Lipidol 1997; 8: 189–196.
5. Johnson WJ, Bamberger MJ, Latta RA, Rapp PE, Phillips MC, Rothblat GH. The bidirectional flux of cholesterol between cells and lipoproteins: effects of phospholipid depletion of high-density lipoprotein. J Biol Chem 1986; 261: 5766–5776.
6. Azizi F, Rahmani M, Majid M. Tehran Lipid and Glucose Study (TLGS): rationale and design. Cardiovasc Dis Prev 2000; 3: 50–53.
7. Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P, Sarbazi N. A serum lipid level in an Iranian adult's population: Tehran Lipid and Glucose Study. Eur J Epidemiol 2003; 18: 311–319.
8. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diabetes Res Clin Pract 2003; 61: 29–37.
9. Truett GE, Walker JA, Ttuett A, Mynatt RL, Heeger P, Warman M. Preparation of PCR-Quality DNA with Hot Sodium Hydroxide and Tris (HOTSHOT). Biotechniques 2000; 29: 52–54.
10. Guerra R, Wang J, Grundy SM, Cohen JC. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high-density lipoprotein cholesterol. Proc Natl Acad Sci USA 1997; 94: 4532–4537.
11. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High-density lipoprotein as a protective factor against coronary heart disease: the Framingham Heart Study. Am J Med 1977; 62: 707–714.
12. Azizi F, Raiszadeh F, Salehi P, Rahmani M, Emami H, Ghanbarian A, Hajipour R. Determinants of serum HDL-C level in Tehran urban population: Tehran Lipid and Glucose Study. Nutr Metab Cardiovasc Dis 2002; 12: 80–89.
13. Zambon A, Deeb SS, Hokanson JE, Brown BG, Brunzell JD. Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. Arterioscler Thromb Vasc Biol 1998; 18: 1723–1729.
14. Vega GL, Clark LT, Tang A, Marcovina S, Grundy SM, Cohen JC. Hepatic lipase activity is lower in African American men than in white American men: effects of 59 flanking polymorphism in the hepatic lipase gene (LIPC). J Lipid Res 1998; 39: 228–232.